Alison E Fox-Robichaud
Overview
Explore the profile of Alison E Fox-Robichaud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thirugnanasampanthar M, Tian L, Rhem R, Libera D, Gomez M, Jackson K, et al.
PNAS Nexus
. 2024 Nov;
3(11):pgae473.
PMID: 39529911
Viable pathogen-laden droplets of consistent quality are essential for reliably assessing the protection offered by facemasks against airborne infections. We identified a significant gap in guidance within standardized tests for...
2.
Gyorffy V, Dwivedi D, Liaw P, Fox-Robichaud A, Tsang J, Binnie A
PLoS One
. 2024 Oct;
19(10):e0311921.
PMID: 39480839
Background: Biosampling studies in critically ill patients traditionally involve bedside collection of samples followed by local processing (ie. centrifugation, aliquotting, and freezing) and storage. However, community hospitals, which care for...
3.
Sheikh F, Douglas W, Diao Y, Correia R, Gregoris R, Machon C, et al.
Can J Anaesth
. 2024 Jul;
71(10):1397-1405.
PMID: 38955983
Purpose: We aimed to identify whether social determinants of health (SDoH) are associated with the development of sepsis and assess the differences between individuals living within systematically disadvantaged neighbourhoods compared...
4.
Fernando S, Tran A, Soliman K, Flynn B, Oommen T, Wenzhe L, et al.
Crit Care Explor
. 2024 Jun;
6(7):e1110.
PMID: 38904978
Objectives: Although clinicians may use methylene blue (MB) in refractory septic shock, the effect of MB on patient-important outcomes remains uncertain. We conducted a systematic review and meta-analysis to investigate...
5.
Kho M, Berney S, Pastva A, Kelly L, Reid J, Burns K, et al.
NEJM Evid
. 2024 Jun;
3(7):EVIDoa2400137.
PMID: 38865147
Background: Critical illness requiring invasive mechanical ventilation can precipitate important functional disability, contributing to multidimensional morbidity following admission to an intensive care unit (ICU). Early in-bed cycle ergometry added to...
6.
Fox-Robichaud A, Bunch J
Intensive Crit Care Nurs
. 2024 May;
83:103714.
PMID: 38776746
No abstract available.
7.
Sheikh F, Chechulina V, Garber G, Hendrick K, Kissoon N, Proulx L, et al.
Healthc Manage Forum
. 2024 Apr;
37(5):366-370.
PMID: 38597370
Sepsis is a global health threat with significant morbidity and mortality. Despite clinical practice guidelines and developed health systems, sepsis is often unrecognized or misdiagnosed, leading to preventable harm. In...
8.
Lamy A, Sirota D, Jacques F, Poostizadeh A, Noiseux N, Efremov S, et al.
Circulation
. 2024 Apr;
150(17):1315-1323.
PMID: 38587333
Background: Although intravenous tranexamic acid is used in cardiac surgery to reduce bleeding and transfusion, topical tranexamic acid results in lower plasma concentrations compared with intravenous tranexamic acid, which may...
9.
Sharma N, Chen A, Heinen L, Liu R, Dwivedi D, Zhou J, et al.
Intensive Care Med Exp
. 2024 Mar;
12(1):28.
PMID: 38457063
Introduction: Despite older adults being more vulnerable to sepsis, most preclinical research on sepsis has been conducted using young animals. This results in decreased scientific validity since age is an...
10.
Madarati H, Singh K, Sparring T, Andrisani P, Liaw P, Fox-Robichaud A, et al.
Shock
. 2023 Dec;
61(2):189-196.
PMID: 38150358
Sepsis is defined as a life-threatening organ dysfunction caused by excessive host response to infection, and represents the most common cause of in-hospital deaths. Sepsis accounts for 30% of all...